Silvant Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Silvant Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-25,426	Closed	-$1.18M	–	348
2019 Q2	$1.18M	Hold	25,426	–	–	0.21%	89
2019 Q1	$620K	Hold	25,426	–	–	0.11%	104
2018 Q4	$362K	Hold	25,426	–	–	0.07%	129
2018 Q3	$386K	Hold	25,426	–	–	0.05%	145
2018 Q2	$427K	Hold	25,426	–	–	0.05%	129
2018 Q1	$415K	Buy	+25,426	New	+$407K	0.05%	132

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Silvant Capital Management's ARRY Position: Q3 2019 in Review

Silvant Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 25,426 shares — an estimated $1.18M sold.

Silvant Capital Management first reported a position in ARRY in Q1 2018 and held it in 6 quarters. The position peaked at $1.18M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Silvant Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Silvant Capital Management sold 25,426 Array Biopharma Inc shares in Q3 2019, an estimated $1.18M.
Silvant Capital Management first reported a position in Array Biopharma Inc in Q1 2018 and held it in 6 quarters.
Silvant Capital Management's Array Biopharma Inc position peaked at $1.18M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Silvant Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.